Fig. 2From: Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathwaysRegulatory, policy and business model tasks related to the development of ivermectin as a complementary tool to reduce malaria transmission. The intended order is left to right but the figure should illustrate the fact that some processes will be conducted in parallel and some sequentially. PTRS probability of technical and regulatory success, WHO-PQ WHO prequalificationBack to article page